Serum prolactin levels in newly admitted psychiatric patients.
D000208:Acute Disease; D001714:Bipolar Disorder / Q000097:blood; D002641:Chicago; D002746:Chlorpromazine / Q000627:therapeutic use; D002908:Chronic Disease; D003863:Depression / Q000097:blood; D004305:Dose-Response Relationship, Drug; D005260:Female; D005476:Fluphenazine / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009519:New York City; D011388:Prolactin / Q000097:blood*; D011618:Psychotic Disorders / Q000097:blood* / Q000188:drug therapy; D011863:Radioimmunoassay; D012559:Schizophrenia / Q000097:blood; D012563:Schizophrenia, Paranoid / Q000097:blood; D013881:Thioridazine / Q000627:therapeutic use; D013997:Time Factors; D014268:Trifluoperazine / Q000627:therapeutic use
D014268:Trifluoperazine; D011388:Prolactin; D013881:Thioridazine; D005476:Fluphenazine; D002746:Chlorpromazine